Life360 director sells 4,000 shares via 10b5-1 plan

Life360, Inc. director John Philip Coghlan reported indirect open-market sales of 4,000 shares of common stock on May 1, 2026.

Rhea-AI Filing Summary

Life360, Inc. director John Philip Coghlan reported indirect open-market sales of 4,000 shares of common stock on May 1, 2026. The shares, held by the John Coghlan Living Trust, were sold in two transactions at weighted average prices of $44.12 and $44.67 per share. These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025. Following the transactions, the trust held 32,431 shares, a separate 2025 Grantor Retained Annuity Trust held 55,494 shares, and Coghlan also reported 836 restricted stock units, each representing one future share upon vesting.

Insights

Equity markets analyst

Routine pre-planned sale of 4,000 Life360 shares via trust.

Director John Philip Coghlan reported selling 4,000 shares of Life360 common stock on May 1, 2026 through the John Coghlan Living Trust. The weighted average sale prices were $44.12 and $44.67 per share in open-market transactions.

The filing notes the sales occurred under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, meaning the trades followed a predetermined formula rather than discretionary timing. After these transactions, the Living Trust held 32,431 shares, and a separate 2025 Grantor Retained Annuity Trust held 55,494 shares.

Coghlan also reported 836 restricted stock units, each convertible into one share upon vesting, indicating continued equity-based exposure. Given the modest 4,000-share net sale relative to the visible indirect holdings, this filing reads as a routine liquidity event under an established plan.

Insider Trade Summary 10b5-1

Net Seller: 4,000 shares

Net Sell 4 txns

Insider COGHLAN JOHN PHILIP

Role Director

Sold 4,000 shs ($177K)

Type	Security	Shares	Price	Value
Sale	Common stock	3,736	$44.12	$165K
Sale	Common stock	264	$44.67	$12K
holding	Common stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common stock — 32,431 shares (Indirect, Held by the John Coghlan Living Trust); Common stock — 836 shares (Direct); Common Stock — 55,494 shares (Indirect, Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust)

Footnotes (4)

1. F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
2. F2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $43.59 to $44.56, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
3. F3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.59 to $44.70, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
4. F4. Represents 836 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Key Figures

Shares sold: 4,000 shares Weighted average sale price 1: $44.12 per share Weighted average sale price 2: $44.67 per share +3 more

6 metrics

Shares sold 4,000 shares Net shares sold on May 1, 2026 by John Coghlan Living Trust

Weighted average sale price 1 $44.12 per share Open-market sale of 3,736 shares on May 1, 2026

Weighted average sale price 2 $44.67 per share Open-market sale of 264 shares on May 1, 2026

Living Trust holdings after sale 32,431 shares John Coghlan Living Trust balance following reported transactions

GRAT holdings 55,494 shares Shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust

Restricted stock units 836 RSUs Each RSU represents a right to one share upon vesting

Key Terms

Rule 10b5-1 trading plan, Grantor Retained Annuity Trust, restricted stock units, weighted average price, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Grantor Retained Annuity Trust financial

"Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust"

A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.

restricted stock units financial

"Represents 836 restricted stock units, each of which represents a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average price financial

"The price reported in Column 4 is the weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

How many Life360 (LIF) shares were sold in John Philip Coghlan’s latest Form 4?

The Form 4 reports that 4,000 shares of Life360 common stock were sold. These were indirect holdings of the John Coghlan Living Trust and were executed in two open-market transactions on May 1, 2026 under a Rule 10b5-1 plan.

At what prices did John Philip Coghlan’s trust sell Life360 (LIF) shares?

The trust’s sales occurred at weighted average prices of $44.12 and $44.67 per share. Footnotes state each average reflects multiple trades within price ranges between roughly $43.59 and $44.70 per share, all completed on May 1, 2026.

Were John Philip Coghlan’s Life360 (LIF) share sales pre-planned under Rule 10b5-1?

Yes. The filing specifies the transactions were executed pursuant to a Rule 10b5-1 trading plan. This plan was adopted on December 8, 2025 and automatically sells shares based on a predetermined formula set when Coghlan was not aware of material nonpublic information.

How many Life360 (LIF) shares does the John Coghlan Living Trust hold after the reported sales?

After the reported transactions, the John Coghlan Living Trust held 32,431 shares of Life360 common stock. This figure reflects the remaining indirect holdings in that trust following the 4,000 shares sold on May 1, 2026 as disclosed in the Form 4.

What additional Life360 (LIF) holdings linked to John Philip Coghlan are shown in this Form 4?

The filing shows 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust and 836 restricted stock units. Each restricted stock unit represents a contingent right to receive one Life360 common share upon vesting, indicating further equity exposure.

What do the 836 restricted stock units in the Life360 (LIF) Form 4 represent?

The 836 restricted stock units are an equity award, each representing a contingent right to one Life360 common share upon vesting. They are reported as direct holdings and will convert into common stock over time as vesting conditions are satisfied.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/05/2026 - 06:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COGHLAN JOHN PHILIP

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CALIFORNIA 94403

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	05/01/2026		S(1)		3,736	D	$44.12(2)	32,695	I	Held by the John Coghlan Living Trust
Common stock	05/01/2026		S(1)		264	D	$44.67(3)	32,431	I	Held by the John Coghlan Living Trust
Common stock								836(4)	D
Common Stock								55,494	I	Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $43.59 to $44.56, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.59 to $44.70, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

4. Represents 836 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Remarks:

	/s/ Jay Sood, as Attorney-in-Fact	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)